Altered expression of genes involved in lipid metabolism in obese subjects with unfavourable phenotype

Genes and Nutrition

Volumn 8, Issue 4, 2013, Pages 425-434

  Telle Hansen, V H ^a,b   Halvorsen, B ^c   Dalen, K T ^b   Narverud, I ^a,b   Wesseltoft Rao, N ^a,b   Granlund, L ^d   Ulven, S M ^a   Holven, K B ^b  

^a OSLO METROPOLITAN UNIVERSITY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Mills DA   (Norway)

Author keywords

Gene expression; Lipid metabolism; Metabolically healthy obese; PBMC

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FATTY ACID; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE SENSITIVE LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 2;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; LIPID METABOLISM; MALE; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN FUNCTION; RISK ASSESSMENT;

EID: 84879690903     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-012-0329-z     Document Type: Article

References (29)

1. Barish GD, Narkar VA, Evans RM (2006) PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest 116:590-597. doi: 10.1172/JCI27955
2. Bouwens M, Afman LA, Muller M (2007) Fasting induces changes in peripheral blood mononuclear cell gene expression profiles related to increases in fatty acid beta-oxidation: functional role of peroxisome proliferator activated receptor alpha in human peripheral blood mononuclear cells. Am J Clin Nutr 86:1515-1523
3. Bouwens M, Afman LA, Muller M (2008) Activation of peroxisome proliferator-activated receptor alpha in human peripheral blood mononuclear cells reveals an individual gene expression profile response. BMC Genom 9:262. doi: 10.1186/1471-2164-9-262
4. Bouwens M, Grootte Bromhaar M, Jansen J, Muller M, Afman LA (2010) Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles. Am J Clin Nutr 91:208-217. doi: 10.3945/ajcn.2009.28586
5. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86:1020-1025
6. Dalgaard LT (2011) Genetic variance in uncoupling protein 2 in relation to obesity, Type 2 diabetes, and related metabolic traits: focus on the functional -866G > A promoter variant (rs659366). J Obes 2011:340241. doi: 10.1155/2011/340241
7. Dalgaard LT, Pedersen O (2001) Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia 44:946-965. doi: 10.1007/s001250100596
8. Fisler JS, Warden CH (2006) Uncoupling proteins, dietary fat and the metabolic syndrome. Nutr Metab (Lond) 3:38. doi: 10.1186/1743-7075-3-38
9. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860-867. doi: 10.1038/nature05485
10. Karelis AD, Brochu M, Rabasa-Lhoret R (2004a) Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 30:569-572
11. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET (2004b) Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89:2569-2575. doi: 10.1210/jc.2004-0165
12. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408. doi: 10.1006/meth.2001.1262
13. Marx N, Mackman N, Schonbeck U, Yilmaz N, Hombach V, Libby P, Plutzky J (2001) PPARalpha activators inhibit tissue factor expression and activity in human monocytes. Circulation 103:213-219
14. Marx N, Kehrle B, Kohlhammer K, Grub M, Koenig W, Hombach V, Plutzky J (2002) PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res 90:703-710
15. Mendez-Sanchez N, Arrese M, Zamora-Valdes D, Uribe M (2007) Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int 27:423-433. doi: 10.1111/j.1478-3231.2007.01483.x
16. Mojiminiyi OA, Abdella NA, Al Mohammedi H (2010) Higher levels of alanine aminotransferase within the reference range predict unhealthy metabolic phenotypes of obesity in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus. J Clin Hypertens (Greenwich) 12:301-308. doi: 10.1111/j.1751-7176.2009.00238.x
17. Mulder H, Sorhede-Winzell M, Contreras JA, Fex M, Strom K, Ploug T, Holm C (2003) Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. J Biol Chem 278:36380-36388. doi: 10.1074/jbc.M213032200
18. Ooi EM, Watts GF, Sprecher DL, Chan DC, Barrett PH (2011) Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity. J Clin Endocrinol Metab 96:E1568-E1576. doi: 10.1210/jc.2011-1131
19. Pecqueur C, Alves-Guerra C, Ricquier D, Bouillaud F (2009) UCP2, a metabolic sensor coupling glucose oxidatin to mitochondrial metabolism? IUBMB Life 61:762-767. doi: 10.1002/iub.188
20. Reid BN, Ables GP, Otlivanchik OA, Schoiswohl G, Zechner R, Blaner WS, Huang LS (2008) Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J Biol Chem 283:13087-13099. doi: 10.1074/jbc.M800533200
21. Riserus U, Sprecher D, Johnson T et al (2008) Activation of peroxisome proliferator activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes 57:332-339
22. Sanderson LM, Degenhardt T, Koppen A, Kalkhoven E, Desvergne B, Muller M, Kersten S (2009) Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver. Mol Cell Biol 29:6257-6267. doi: 10.1128/MCB.00370-09
23. Sekiya M, Osuga J, Yahagi N, Okazaki H, Tamura Y, Igarashi M, Ishibashi S (2008) Hormone-sensitive lipase is involved in hepatic cholesteryl ester hydrolysis. J Lipid Res 49:1829-1838. doi: 10.1194/jlr.M800198-JLR200
24. Sims EA (2001) Are there persons who are obese, but metabolically healthy? Metabolism 50:1499-1504. doi: 10.1053/meta.2001.27213
25. Strable MS, Ntambi JM (2010) Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol 45:199-214. doi: 10.3109/10409231003667500
26. Taskinen MR, Adiels M, Westerbacka J, Söderlund S, Kahri J, Lundbom N, Lundbom J, Hakkarainen A, Olofsson SO, Orho-Melander M, Borén J (2011) Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects. Arterioscler Thromb Vasc Biol 31:2144-2150
27. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:1889-1895
28. Wannamethee SG, Shaper AG, Lennon L, Whincup PH (2005) Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28:2913-2918
29. Wildman RP (2009) Healthy obesity. Curr Opin Clin Nutr Metab Care 12:438-443. doi: 10.1097/MCO.0b013e32832c6db7